Ratings Ramsay Health Care Limited

Equities

RHC

AU000000RHC8

Market Closed - Australian S.E. Other stock markets 07:10:57 27/06/2024 BST			5-day change	1st Jan Change
47.18 ^AUD	+1.27%		-3.14%	-10.32%

06-20	IHH, Sunway among bidders for Affinity's Malaysian hospital, sources say	RE
06-17	Ramsay Health Care Unit Acquires 11 Medical, Dental Centers in France	MT

Summary

According to Refinitiv, the company's ESG score for its industry is good.

Strengths

Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

Weaknesses

The company sustains low margins.
The company is in debt and has limited leeway for investment
With a 2024 P/E ratio at 19.76 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The valuation of the company is particularly high given the cash flows generated by its activity.
For the last few months, analysts have been revising downwards their earnings forecast.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
RAMSAY HEALTH CARE LIMITED	-10.32%	7.09B		A-
AIER EYE HOSPITAL GROUP CO., LTD.	-32.30%	13.7B		B+
IHH HEALTHCARE	+3.98%	11.72B		B+
BANGKOK DUSIT MEDICAL SERVICES	-3.60%	11.51B		B
APOLLO HOSPITALS ENTERPRISE LIMITED	+7.64%	10.56B		B+
ENCOMPASS HEALTH CORPORATION	+26.78%	8.52B		B
THE ENSIGN GROUP, INC.	+7.53%	6.81B		B-
MOUWASAT MEDICAL SERVICES COMPANY	+8.23%	6.48B		D
CONCORD HEALTHCARE GROUP CO., LTD.	0.00%	4.89B	-	-
FORTIS HEALTHCARE LIMITED	+15.92%	4.35B		B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes